Victor Ortega is a Respiratory physician. OpenAlex indexes 365 publications with 7,742 citations (h-index 39); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Medical Center Blvd
Winston Salem, NC 271570001
Telephone
336-716-2255Provider last certified this registry record 27 Jan 2022.
Clinical trials
- Study of COPD Subgroups and Biomarkers
Sponsor: University of North Carolina, Chapel Hill
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Merck Sharp & Dohme LLCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
68.8%Corticosteroid56.3%Symbicort19%Qvar Redihaler18%Breyna17%Budesonide-Formoterol Fumarate14%Breztri Aerosphere12%Dulera9%Breo Ellipta6%Trelegy Ellipta5%Part D<11 patientsbeta2-Adrenergic Agonist7.7%Albuterol Sulfate Hfa79%Airsupra21%Part D<11 patients+ 2 more classes in this area
Anti-infectives
19.2%Macrolide Antimicrobial17.5%Azithromycin100%Part D≥23 patientsShort-acting sulfonamides1.7%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsMetabolism & gastrointestinal
4.6%Corticosteroid2.7%Prednisone100%Part D≥12 patientsProton pump inhibitor1.9%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2015–2022 per NIH RePORTER. The latest:
- Non-coding RNA structure change in Chronic Obstructive Pulmonary Disease
Univ of North Carolina Chapel Hill
FY2022$520,208R01HL111527 - Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD
Wake Forest University Health Sciences
FY2021$751,239R01HL142992 - Non-coding RNA structure change in Chronic Obstructive Pulmonary Disease
Univ of North Carolina Chapel Hill
FY2021$520,208R01HL111527
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement
American Journal of Respiratory and Critical Care Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”